{'fraction_non_alphanumeric': 0.025, 'fraction_numerical': 0.019318181818181818, 'mean_word_length': 5.034246575342466, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Strengthening the research of pancreatogenic diabetes

Type 3c diabetes mellitus (T3cDM) is a diabetes mellitus secondary to pancreatic diseases. It is previously believed that the prevalence of this disease was low, accounting for 0.5%–1.15% of the diabetes population. Recent data on type 3c diabetes (T3cDM) showed that it might be more common than reported previously. It is 5%–10% among all diabetic subjects in Western populations. Its prevalence and clinical importance have been underestimated and underappreciated. In contrast to the management of type 1 or type 2 diabetes, the pathogenesis of T3cDM is very complex and complicated. The failure to correctly diagnose T3cDM may lead to failure to implement an appropriate medical therapy on these patients. The purpose of this review is to draw attention to T3cDM and to strengthen research and diagnosis of this disease.